Priority Date: 10.04.12 (US 201213443023)

METHOD OF USING NUTRITIONAL COMPOUNDS DIHYDROQUERCETIN (TAXIFOLIN) AND ARABINOGALACTAN IN COMBINATION WITH DIHYDROQUERCETIN (TAXIFOLIN) TO REDUCE AND CONTROL CARDIOMETABOLIC RISK FACTORS ASSOCIATED WITH METABOLIC SYNDROME AND HYPERCHOLESTEROLEMIA

  • Application ID: EP12874065
  • Status: EXAMINATION IN PROGRESS

Applicant

Technology company logo small
Technology Company

Attorney

operating since 1995
1165.89
Headquarter in Leeds and 13 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A23 (FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES) and A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) is specialized in the combination A23 and A61. We found, that Engel Patentanwaltskanzlei, Vereenigde Octrooibureaux NV (V.O.), Høiberg A/S, Katzarov SA, Hepp Wenger Ryffel AG and 59 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 10.04.2012 - Priority Date (US 201213443023)
  • 17.10.2013 - Publication A1 (WO2013154516)
  • 24.12.2014 - Publication A2 (EP2814336)